{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:56:46Z","timestamp":1785938206469,"version":"3.56.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Cardiology"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1097\/00001573-199803000-00007","type":"journal-article","created":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T04:52:04Z","timestamp":1160628724000},"page":"111-116","source":"Crossref","is-referenced-by-count":4,"title":["Do calcium channel blockers and HMG-CoA reductase inhibitors attenuate a I log raft arteriopathy?"],"prefix":"10.1097","volume":"13","author":[{"given":"Hannah A.","family":"Valantine-von Kaeppler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001573-199803000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:40:06Z","timestamp":1785937206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001573-199803000-00007"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1097\/00001573-199803000-00007","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}